Vogt Frederick G bought IOVA
March 2, 2026 · Form 4 insider transaction
Vogt Frederick G bought 52,087 shares of Iovance Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
52,087
Price
$0.00
Total value
N/A
InsiderVogt Frederick G
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after516,609
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.